Ascletis announces expansion of Ritonavir oral tablet production capacity to 530 million tablets per…
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targetting viral proteases and a component of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ascletis Pharma
Ascletis announces signing of Ritonavir tablet purchase agreement with Phokam Pharmaceutical
Ritonavir oral tablet is a component of oral antiviral drug Paxlovid
Gannex receives US IND Approval for NASH drug candidate, an FXR agonist
In two NASH animal models, ASC42 demonstrated significant improvements in liver steatosis, inflammation and fibrosis